易善复治疗90例非酒精性脂肪肝患者的临床疗效分析  

Clinical Analysis of Essentiale Treatment of 90 Patients with Non-alcoholic Fatty Liver

作　　者：南君[1] 

机构地区：[1]河南省商丘市第一人民医院消化内科,河南商丘476100

出　　处：《中国医药指南》2011年第35期249-250,共2页Guide of China Medicine

摘　　要：目的分析并探讨易善复在治疗非酒精性脂肪肝方面的临床疗效。方法对我院自2009年12月至2011年2月期间收治的180例非酒精性脂肪肝患者,分成两组,分别采用易善复与甘利欣进行治疗,并对疗效进行对比分析。结果观察组治疗前后ALT、AST及TG差异均显著(P<0.05),具统计学意义;对照组治疗前后TG水平无明显差异(P>0.05),不具统计学意义;观察组有效率为94.44%(85/90),对照组有效率为68.89%(62/90),两组比较差异显著(P<0.05),具统计学意义。结论易善复在非酒精性脂肪肝的治疗方面疗效理想,值得广泛推广应用。Objective To analyze and explore Essentiale in the treatment of non-alcoholic fatty liver disease in clinical efficacy. Methods The hospital from December 2009-February 2011 period, 180 cases of non-admitted alcoholic fatty liver disease were divided into two groups, respectively Essentiale and glycyrrhizin for treatment, and efficacy were analyzed. Results The before and after treatment ALT, AST and TG were significant differences （P 〈0.05）, statistically significant; the control group before and after treatment no significant difference in TG levels （P〉0.05）, not statistically significant; observation group was 94.44% （85/90） in the control group was 68.89% （62/90）, the difference was significant （P〈0.05）, with statistical significance. Conclusion Essantiale non-alcoholic fatty liver in the treatment efficacy of an ideal, it is widely used.

关 键 词：非酒精性脂肪肝 NASH 易善复 临床疗效 

分 类 号：R575.5[医药卫生—消化系统]